Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

233 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Targeting the endocannabinoid system in cancer therapy: a call for further research.
Bifulco M, Di Marzo V. Bifulco M, et al. Nat Med. 2002 Jun;8(6):547-50. doi: 10.1038/nm0602-547. Nat Med. 2002. PMID: 12042794 Review. No abstract available.
The cannabinoid CB1 receptor antagonist rimonabant (SR141716) inhibits human breast cancer cell proliferation through a lipid raft-mediated mechanism.
Sarnataro D, Pisanti S, Santoro A, Gazzerro P, Malfitano AM, Laezza C, Bifulco M. Sarnataro D, et al. Among authors: bifulco m. Mol Pharmacol. 2006 Oct;70(4):1298-306. doi: 10.1124/mol.106.025601. Epub 2006 Jul 5. Mol Pharmacol. 2006. PMID: 16822929
A new strategy to block tumor growth by inhibiting endocannabinoid inactivation.
Bifulco M, Laezza C, Valenti M, Ligresti A, Portella G, DI Marzo V. Bifulco M, et al. FASEB J. 2004 Oct;18(13):1606-8. doi: 10.1096/fj.04-1754fje. Epub 2004 Aug 2. FASEB J. 2004. PMID: 15289448
Inhibitory effects of cannabinoid CB1 receptor stimulation on tumor growth and metastatic spreading: actions on signals involved in angiogenesis and metastasis.
Portella G, Laezza C, Laccetti P, De Petrocellis L, Di Marzo V, Bifulco M. Portella G, et al. Among authors: bifulco m. FASEB J. 2003 Sep;17(12):1771-3. doi: 10.1096/fj.02-1129fje. Epub 2003 Jul 3. FASEB J. 2003. PMID: 12958205
Possible endocannabinoid control of colorectal cancer growth.
Ligresti A, Bisogno T, Matias I, De Petrocellis L, Cascio MG, Cosenza V, D'argenio G, Scaglione G, Bifulco M, Sorrentini I, Di Marzo V. Ligresti A, et al. Among authors: bifulco m. Gastroenterology. 2003 Sep;125(3):677-87. doi: 10.1016/s0016-5085(03)00881-3. Gastroenterology. 2003. PMID: 12949714
Cannabinoid receptor CB1 antagonists state of the art and challenges.
Bifulco M, Santoro A, Laezza C, Malfitano AM. Bifulco M, et al. Vitam Horm. 2009;81:159-89. doi: 10.1016/S0083-6729(09)81007-8. Vitam Horm. 2009. PMID: 19647112 Review.
Interaction of endocannabinoid system and steroid hormones in the control of colon cancer cell growth.
Proto MC, Gazzerro P, Di Croce L, Santoro A, Malfitano AM, Pisanti S, Laezza C, Bifulco M. Proto MC, et al. Among authors: bifulco m. J Cell Physiol. 2012 Jan;227(1):250-8. doi: 10.1002/jcp.22727. J Cell Physiol. 2012. PMID: 21412772
Update on the endocannabinoid system as an anticancer target.
Malfitano AM, Ciaglia E, Gangemi G, Gazzerro P, Laezza C, Bifulco M. Malfitano AM, et al. Among authors: bifulco m. Expert Opin Ther Targets. 2011 Mar;15(3):297-308. doi: 10.1517/14728222.2011.553606. Epub 2011 Jan 19. Expert Opin Ther Targets. 2011. PMID: 21244344 Review.
The endocannabinoid system and its therapeutic exploitation.
Di Marzo V, Bifulco M, De Petrocellis L. Di Marzo V, et al. Among authors: bifulco m. Nat Rev Drug Discov. 2004 Sep;3(9):771-84. doi: 10.1038/nrd1495. Nat Rev Drug Discov. 2004. PMID: 15340387 Review.
Anandamide inhibits adhesion and migration of breast cancer cells.
Grimaldi C, Pisanti S, Laezza C, Malfitano AM, Santoro A, Vitale M, Caruso MG, Notarnicola M, Iacuzzo I, Portella G, Di Marzo V, Bifulco M. Grimaldi C, et al. Among authors: bifulco m. Exp Cell Res. 2006 Feb 15;312(4):363-73. doi: 10.1016/j.yexcr.2005.10.024. Epub 2005 Dec 15. Exp Cell Res. 2006. PMID: 16343481
233 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page